Why no NPs or PAs!?!

Quote


















anonymous said:
You better hope this product takes off or else we are ALL leaving you.
Click to expand...

This whole thread is the dumbest argument I have ever seen. You’ve got one dumb dumb being dramatic and threatening management with what sounds like a labor strike. And then you got this other dbag that is obviously just trying to poke the bear with nasty sexist comments.

Do your job, whatever that job is. Do it well and we all win. We play for the same team people.
 






anonymous said:
This whole thread is the dumbest argument I have ever seen. You’ve got one dumb dumb being dramatic and threatening management with what sounds like a labor strike. And then you got this other dbag that is obviously just trying to poke the bear with nasty sexist comments.

Do your job, whatever that job is. Do it well and we all win. We play for the same team people.
Click to expand...

Unapologetic back to back poster here. I’m also not sold on the fact that the aforementioned dbag(s) aren’t the same person playing both roles to stir sh*t up....
 


















Ever heard of a product launched by Shire known as Daytrana? That’s what Qelbree will be. Within 18 months Qelbree will be such a bust that Supernus will offload it to another company.
 










































anonymous said:
Ever heard of a product launched by Shire known as Daytrana? That’s what Qelbree will be. Within 18 months Qelbree will be such a bust that Supernus will offload it to another company.
Click to expand...

I just want to get this straight. You are comparing Daytrana, a reformulation of methylphenidate as a transdermal patch(that still show how generated $97M/year) to Qelbree, a nonscheduled NCE? Apples and oranges bro.

P.S. you just gave your identity away. Bringing up Daytrana = worked for Shire bc no one else knows that name. Sh*t talking Qelbree = not a current Supernus employee. Put the 2 together aaaaaand
 












anonymous said:
I just want to get this straight. You are comparing Daytrana, a reformulation of methylphenidate as a transdermal patch(that still show how generated $97M/year) to Qelbree, a nonscheduled NCE? Apples and oranges bro.

P.S. you just gave your identity away. Bringing up Daytrana = worked for Shire bc no one else knows that name. Sh*t talking Qelbree = not a current Supernus employee. Put the 2 together aaaaaand
Click to expand...

Do you think it’s possible I’m an analyst? Idiot.
 
























Top Bottom
Back
Quote